← Open Payments lookup

JESSICA CABRERA: Open Payments

NPI 1265641435 · HARLINGEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,969 in 69 payments from 11 companies in 2025. Trend: 2023 $1,780 · 2024 $1,700 · 2025 $2,969

Food & beverage: $2,855Education: $114
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.11$568
Teva Pharmaceuticals USA, Inc.12$524
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$411
ABBVIE INC.5$299
Alkermes, Inc.4$284
Vanda Pharmaceuticals Inc.5$279
Neurocrine BioSciences, Inc.4$202
E.R. Squibb & Sons, L.L.C.10$191
Axsome Therapeutics, Inc.6$162
Lundbeck LLC1$25

Products named: REXULTI, CAPLYTA, UZEDY, VRAYLAR, FANAPT, LYBALVI, INGREZZA, COBENFY.

Industry payments across TX — which companies pay providers there.